Publications by authors named "Marie Elebring"

Claim this Profile
I
Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration.
Asmaa McGowan, Peter Gennemark, Marceline Akieh-Pirkanniemi, Linda Wirman, Nigel Davies, Marie Elebring

Mol Pharm· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling.
Jin Dong, Luna Prieto Garcia, Yingbo Huang, Weifeng Tang, Anna Lundahl, Marie Elebring

Clin Pharmacol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Metabolite Profiles of an -Acetylgalactosamine-Conjugated Antisense Oligonucleotide AZD8233 Using Liquid Chromatography High-Resolution Mass Spectrometry: A Cross-Species Comparison in Animals and Humans.
Xue-Qing Li, Marie Elebring, Anders Dahlén, Lars Weidolf

Drug Metab Dispos· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates.
Lars Weidolf, Anders Björkbom, Anders Dahlén, Marie Elebring, Peter Gennemark

Drug Discov Today· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oral antisense oligonucleotide for PCSK9 inhibition.
Peter Gennemark, Katrin Walter, Niclas Clemmensen, Dinko Rekić, Catarina A M Nilsson, Marie Elebring

Sci Transl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development' Drug Discovery Today 23 (2018) 1733-1745.
Shalini Andersson, Madeleine Antonsson, Marie Elebring, Rasmus Jansson-Löfmark, Lars Weidolf

Drug Discov Today· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development.
Shalini Andersson, Madeleine Antonsson, Marie Elebring, Rasmus Jansson-Löfmark, Lars Weidolf

Drug Discov Today· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.
Susanne Johansson, David P Rosenbaum, Marie Ahlqvist, Helen Rollison, Mikael Knutsson, Marie Elebring

Clin Pharmacol Drug Dev· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonists.
J Gerry Kenna, Simone H Stahl, Julie A Eakins, Alison J Foster, Linda C Andersson, Marie Elebring

J Pharmacol Exp Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.
Heike Hellmold, Hui Zhang, Ulf Andersson, Bo Blomgren, Tom Holland, Marie Elebring

Toxicol Sci· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability.
Jason L Johnson, Regina Fritsche-Danielson, Margareta Behrendt, Annika Westin-Eriksson, Håkan Wennbo, Marie Elebring

Cardiovasc Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis